Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$0.82−0.06 (-6.69%)
Close on Nov 13, 2026Market cap $36.32MP/E –Yield –
Elutia statistics
81 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 10, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.49
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 0.90
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 6.42%
- 10.8%
- Float
- 21M
- 49M
- Shares Held by Insiders
- 52.0%
- 11.7%
- Shares Held by Institutions
- 39.8%
- 56.4%
Short sellingIndustry
- Short Interest
- 33,661
- –
- Short Interest Change
- 119.6%
- -0.80%
- Short % of Float
- 0.16%
- 9.01%
- Short % of Shares Outstanding
- 0.08%
- 6.30%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $1.39
- –
- 52-Week Low
- $0.50
- –
- 20-Day Moving Average
- $0.83
- –
- 50-Day Moving Average
- $0.82
- –
- 200-Day Moving Average
- $0.97
- –
- Average True Range (14)
- $0.08
- –
- Price Change (1 Week)
- -2.08%
- -1.15%
- Price Change (1 Month)
- 3.96%
- -4.87%
- Price Change (3 Months)
- -16.0%
- -21.0%
- Price Change (6 Months)
- -20.4%
- -20.6%
- Price Change (YTD)
- 18.4%
- -23.6%
- Price Change (1 Year)
- 10.8%
- -22.4%
- Price Change (3 Years)
- -49.7%
- -29.5%
- Price Change (5 Years)
- -86.9%
- -77.9%
- Average Volume (10 Days)
- 84,400
- –
- Average Volume (20 Days)
- 77,118
- –
- Average Volume (90 Days)
- 156,393
- –
- Relative Volume
- 0.32
- 0.70
- Relative Strength Index (14)
- 48.7
- 43.4
- Volatility (1 Year)
- 76.5%
- 80.1%
- Beta (5 Years)
- 0.25
- 1.07
MarginsIndustry
- Pretax Margin
- -156.5%
- -11.6%
- EBITDA Margin
- -144.2%
- -27.7%
- FCF Margin
- -298.8%
- -9.56%
Returns on capitalIndustry
- Return on Assets (ROA)
- 140.2%
- -40.6%
- Return on Capital Employed (ROCE)
- -80.3%
- -37.9%
Financial positionIndustry
- Current Ratio
- 2.63
- 3.30
- Quick Ratio
- 1.91
- 2.39
- Debt / Equity
- 0.53
- 0.49
GrowthIndustry
- Revenue Growth (YoY)
- 79.4%
- 6.82%
- Revenue Growth (3Y CAGR)
- -19.8%
- 2.25%
- Revenue Growth (5Y CAGR)
- -22.0%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.44
- 0.40
- Inventory Turnover
- 6.29
- 2.73
- Revenue Per Employee
- $652.46K
- $429.29K
- Profits Per Employee
- $2.09M
- -$689.41K
- Employee Count
- 26
- 74
- WACC
- 7.24%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$26.55M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $21.00M
- $17.76M
- Net Cash Per Share
- $0.47
- $0.80
- Equity (Book Value)
- $15.33M
- $53.89M
- Book Value Per Share
- $0.35
- $1.50
- Tangible Book Value
- $14.61M
- $27.13M
- Working Capital
- $26.14M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.45M
- -$1.00M
- FCF Per Share
- -$1.14
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 149.8%
- -21.8%
- FCF Yield
- -139.5%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $75.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -5.70
- 0.23
- Piotroski F-Score
- 6
- 4
- Beneish M-Score
- 4.59
- -2.63
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ELUT | S&P 500 | Difference | ELUT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +6.1% | -3.0% | +9.1 pts | ||
| 3 months | -4.7% | -2.8% | −1.9 pts | ||
| Year to date | +18.4% | +11.5% | +6.9 pts | ||
| 1 year | +10.4% | +13.5% | −3.1 pts | ||
| 3 years | -43.8% | +77.7% | −121.5 pts | -17.5% | +21.1% |
| 5 years | -86.9% | +72.6% | −159.5 pts | -33.4% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M ELUT shares were sold short on Oct 30, 2026, up 119.6% from the previous report, or 0.16% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 43.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 33,661 | +119.6% | 70,790 | 1.0 |
| Oct 15, 2026 | 15,326 | +63.8% | 788,498 | 1.0 |
| Sep 30, 2026 | 9,359 | +13.8% | 29,608 | 1.0 |
| Sep 15, 2026 | 8,223 | -51.5% | 27,409 | 1.0 |
| Aug 31, 2026 | 16,949 | -34.5% | 72,592 | 1.0 |
| Aug 14, 2026 | 25,859 | -34.8% | 40,564 | 1.0 |
| Jul 31, 2026 | 39,655 | -7.7% | 136,001 | 1.0 |
| Jul 15, 2026 | 42,956 | -18.8% | 40,242 | 1.1 |
| Jun 30, 2026 | 52,925 | +106.2% | 82,561 | 1.0 |
| Jun 15, 2026 | 25,665 | -39.8% | 112,225 | 1.0 |
| May 29, 2026 | 42,627 | -69.9% | 104,439 | 1.0 |
| May 15, 2026 | 141,552 | +12.2% | 185,657 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?